Cargando…
Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis pat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642222/ https://www.ncbi.nlm.nih.gov/pubmed/33195328 http://dx.doi.org/10.3389/fmed.2020.579677 |
_version_ | 1783606049071169536 |
---|---|
author | Reisinger, Alexander C. Schuller, Max Holzer, Michael Stadler, Julia T. Hackl, Gerald Posch, Florian Marsche, Gunther Sourij, Harald Ekart, Robert Eller, Kathrin Eller, Philipp |
author_facet | Reisinger, Alexander C. Schuller, Max Holzer, Michael Stadler, Julia T. Hackl, Gerald Posch, Florian Marsche, Gunther Sourij, Harald Ekart, Robert Eller, Kathrin Eller, Philipp |
author_sort | Reisinger, Alexander C. |
collection | PubMed |
description | Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis patients admitted to intensive care unit (ICU). Methods: We prospectively recruited consecutive adult patients with sepsis and septic shock, according to sepsis-3 criteria as well as non-sepsis ICU controls. Results: Fifty-three patients with sepsis (49% with septic shock) and 25 ICU controls without sepsis were enrolled. Dyslipidemia (HDL-C < 40 mg/l) was more common in sepsis compared to non-sepsis patients (85 vs. 52%, p = 0.002). Septic patients compared to controls had reduced HDL-C (14 vs. 39 mg/l, p < 0.0001), lower arylesterase activity of the antioxidative paraoxonase of HDL (AEA) (67 vs. 111 mM/min/ml serum, p < 0.0001), and a non-significant trend toward reduced cholesterol efflux capacity (9 vs. 10%, p = 0.091). We observed a strong association between higher AEA and lower risk of 28-day [per 10 mM/min/ml serum increase in AEA: odds ratio (OR) = 0.76; 95% CI, 0.61–0.94; p = 0.01) and ICU mortality (per 10 mM/min/ml serum increase in AEA: OR = 0.71, 95% CI, 0.56–0.90, p = 0.004) in the sepsis cohort in univariable logistic regression analysis. AEA was confirmed as an independent predictor of 28-day and ICU mortality in multivariable analyses. AEA discriminated well-regarding 28-day/ICU mortality in area under the receiver operating characteristic curve (AUROC) analyses. In survival analysis, 28-day mortality estimates were 40 and 69% with AEA ≥/< the 25th percentile of AEA's distribution, respectively (log-rank p = 0.0035). Conclusions: Both compositional and functional HDL parameters are profoundly altered during sepsis. In particular, the functionality parameter AEA shows promising prognostic potential in sepsis patients. |
format | Online Article Text |
id | pubmed-7642222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76422222020-11-13 Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study Reisinger, Alexander C. Schuller, Max Holzer, Michael Stadler, Julia T. Hackl, Gerald Posch, Florian Marsche, Gunther Sourij, Harald Ekart, Robert Eller, Kathrin Eller, Philipp Front Med (Lausanne) Medicine Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis patients admitted to intensive care unit (ICU). Methods: We prospectively recruited consecutive adult patients with sepsis and septic shock, according to sepsis-3 criteria as well as non-sepsis ICU controls. Results: Fifty-three patients with sepsis (49% with septic shock) and 25 ICU controls without sepsis were enrolled. Dyslipidemia (HDL-C < 40 mg/l) was more common in sepsis compared to non-sepsis patients (85 vs. 52%, p = 0.002). Septic patients compared to controls had reduced HDL-C (14 vs. 39 mg/l, p < 0.0001), lower arylesterase activity of the antioxidative paraoxonase of HDL (AEA) (67 vs. 111 mM/min/ml serum, p < 0.0001), and a non-significant trend toward reduced cholesterol efflux capacity (9 vs. 10%, p = 0.091). We observed a strong association between higher AEA and lower risk of 28-day [per 10 mM/min/ml serum increase in AEA: odds ratio (OR) = 0.76; 95% CI, 0.61–0.94; p = 0.01) and ICU mortality (per 10 mM/min/ml serum increase in AEA: OR = 0.71, 95% CI, 0.56–0.90, p = 0.004) in the sepsis cohort in univariable logistic regression analysis. AEA was confirmed as an independent predictor of 28-day and ICU mortality in multivariable analyses. AEA discriminated well-regarding 28-day/ICU mortality in area under the receiver operating characteristic curve (AUROC) analyses. In survival analysis, 28-day mortality estimates were 40 and 69% with AEA ≥/< the 25th percentile of AEA's distribution, respectively (log-rank p = 0.0035). Conclusions: Both compositional and functional HDL parameters are profoundly altered during sepsis. In particular, the functionality parameter AEA shows promising prognostic potential in sepsis patients. Frontiers Media S.A. 2020-10-22 /pmc/articles/PMC7642222/ /pubmed/33195328 http://dx.doi.org/10.3389/fmed.2020.579677 Text en Copyright © 2020 Reisinger, Schuller, Holzer, Stadler, Hackl, Posch, Marsche, Sourij, Ekart, Eller and Eller. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Reisinger, Alexander C. Schuller, Max Holzer, Michael Stadler, Julia T. Hackl, Gerald Posch, Florian Marsche, Gunther Sourij, Harald Ekart, Robert Eller, Kathrin Eller, Philipp Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title | Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title_full | Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title_fullStr | Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title_full_unstemmed | Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title_short | Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study |
title_sort | arylesterase activity of hdl associated paraoxonase as a potential prognostic marker in patients with sepsis and septic shock—a prospective pilot study |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642222/ https://www.ncbi.nlm.nih.gov/pubmed/33195328 http://dx.doi.org/10.3389/fmed.2020.579677 |
work_keys_str_mv | AT reisingeralexanderc arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT schullermax arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT holzermichael arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT stadlerjuliat arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT hacklgerald arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT poschflorian arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT marschegunther arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT sourijharald arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT ekartrobert arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT ellerkathrin arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy AT ellerphilipp arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy |